BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Aug 09, 2010
 |  BC Week In Review  |  Company News  |  Deals

Cornerstone Therapeutics, Targacept deal

Cornerstone granted Targacept exclusive, worldwide rights to its nicotinic receptor patents and preclinical compounds that target the receptors, including nicotinic acetylcholine receptor alpha 7 (CHRNA7). Cornerstone...

Read the full 130 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >